Arcus Biosciences, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 23,073 | 0.0% | 968,241 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 11,848 | 0.0% | 871,150 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 6,323 | 0.0% | 776,742 | 6/30/2025 |
| 2025 Q1 | 9/15/2025 | 5,605 | 0.0% | 714,002 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 8,631 | 0.0% | 579,623 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 8,669 | 0.0% | 566,979 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 7,728 | 0.0% | 507,443 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 9,313 | 0.0% | 493,276 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 9,019 | 0.0% | 472,182 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 8,272 | 0.0% | 460,841 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 8,870 | 0.0% | 436,741 | 6/30/2023 |
| 2023 Q1 | 5/12/2023 | 7,692 | 0.0% | 421,691 | 3/31/2023 |
| 2022 Q4 | 2/13/2023 | 8,039 | 0.0% | 388,720 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 9,917 | 0.0% | 379,094 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 8,699 | 0.0% | 343,281 | 6/30/2022 |
| 2022 Q1 | 5/13/2022 | 10,436 | 0.0% | 330,651 | 3/31/2022 |
| 2021 Q4 | 2/11/2022 | 13,038 | 0.0% | 322,150 | 12/31/2021 |
| 2021 Q3 | 11/16/2021 | 12,388 | 0.0% | 355,241 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 9,462 | 0.0% | 344,559 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 9,359 | 0.0% | 333,271 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 7,453 | 0.0% | 287,080 | 12/31/2020 |
| 2020 Q3 | 11/13/2020 | 4,851 | 0.0% | 282,973 | 9/30/2020 |
| 2020 Q2 | 8/20/2020 | 6,340 | 0.0% | 256,253 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 2,724 | 0.0% | 196,241 | 3/31/2020 |
| 2019 Q4 | 2/7/2020 | 1,937 | 0.0% | 191,763 | 12/31/2019 |